ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

New chiefs at drug service firms Lonza and Alcami

by Rick Mullin
June 13, 2020 | APPEARED IN VOLUME 98, ISSUE 23

 

Lonza, the world’s largest drug contract development and manufacturing organization (CDMO), has named Pierre-Alain Ruffieux, currently head of pharmaceutical technical operations at Roche, to replace Mark Funk as CEO on Nov. 1. Funk has held the position since March 2019 and is stepping down for personal reasons, Lonza says. Meanwhile, Walter J. Kaczmarek III has been named CEO of the US-based CDMO Alcami. Kaczmarek has been a manager at firms including Aceto and Mallinckrodt.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment